Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Philip Morris' Zyn nicotine pouches land FDA marketing approval
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches ...
Hosted on MSN3h
Morgan Stanley Initiates Coverage of Philip Morris International (PM) with Overweight Recommendation
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
Philip Morris stock rises on FDA's first nicotine pouch approval
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Philip Morris: Growth Potential in Smoke-Free Product Portfolio Fuels Buy Rating
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
FDA Authorizes Zyn Nicotine Pouches
The Food and Drug Administration OK'd 10 Zyn flavors, including coffee, mint and menthol. It's the first time regulators have ...
FDA green-lights Zyn nicotine pouches
The FDA gave marketing authorization to 20 different Zyn products, the most popular nicotine pouch product in the U.S.